This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Selvakumaran, M Articles by Hoffman-Liebermann, B Search for Related Content PubMed PubMed Citation Articles by Selvakumaran, M Articles by Hoffman-Liebermann, B

Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.

Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia 19104-6059.

ABSTRACT

The c-myb proto-oncogene is abundantly expressed in tissues of hematopoietic origin, and changes in endogenous c-myb genes have been implicated in both human and murine hematopoietic tumors. c-myb encodes a DNA-binding protein capable of trans-activating the c-myc promoter. Suppression of both of these proto-oncogenes was shown to occur upon induction of terminal differentiation but not upon induction of growth inhibition in myeloid leukemia cells. Myeloblastic leukemia M1 cells that can be induced for terminal differentiation with the physiological hematopoietic inducers interleukin-6 and leukemia inhibitory factor were genetically manipulated to constitutively express a c-myb transgene. By using immediate-early to late genetic and morphological markers, it was shown that continuous expression of c-myb disrupts the genetic program of myeloid differentiation at a very early stage, which precedes the block previously shown to be exerted by deregulated c-myc, thereby indicating that the c-myb block is not mediated via deregulation of c-myc. Enforced c-myb expression also prevents the loss in leukemogenicity of M1 cells normally induced by interleukin-6 or leukemia inhibitory factor. Any changes which have taken place, including induction of myeloid differentiation primary response genes, eventually are reversed. Also, it was shown that suppression of c-myb, essential for terminal differentiation, is not intrinsic to growth inhibition. Taken together, these findings show that c-myb plays a key regulatory role in myeloid differentiation and substantiate the notion that deregulated expression of c-myb can play an important role in leukemogenicity.

This article has been cited by other articles:

• Nakata, Y., Shetzline, S., Sakashita, C., Kalota, A., Rallapalli, R., Rudnick, S. I., Zhang, Y., Emerson, S. G., Gewirtz, A. M. (2007). c-Myb Contributes to G2/M Cell Cycle Transition in Human Hematopoietic Cells by Direct Regulation of Cyclin B1 Expression. Mol. Cell. Biol. 27: 2048-2058 [Abstract] [Full Text]  
• Tanikawa, J., Nomura, T., Macmillan, E. M., Shinagawa, T., Jin, W., Kokura, K., Baba, D., Shirakawa, M., Gonda, T. J., Ishii, S. (2004). p53 Suppresses c-Myb-induced trans-Activation and Transformation by Recruiting the Corepressor mSin3A. J. Biol. Chem. 279: 55393-55400 [Abstract] [Full Text]  
• Shafarenko, M., Amanullah, A., Gregory, B., Liebermann, D. A., Hoffman, B. (2004). Fos modulates myeloid cell survival and differentiation and partially abrogates the c-Myc block in terminal myeloid differentiation. Blood 103: 4259-4267 [Abstract] [Full Text]  
• Kanei-Ishii, C., Ninomiya-Tsuji, J., Tanikawa, J., Nomura, T., Ishitani, T., Kishida, S., Kokura, K., Kurahashi, T., Ichikawa-Iwata, E., Kim, Y., Matsumoto, K., Ishii, S. (2004). Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev. 18: 816-829 [Abstract] [Full Text]  
• Kumar, A., Lee, C. M., Reddy, E. P. (2003). c-Myc Is Essential but Not Sufficient for c-Myb-mediated Block of Granulocytic Differentiation. J. Biol. Chem. 278: 11480-11488 [Abstract] [Full Text]  
• Richardson, R. T., Starr, R., Angus, L. J. L., Hilton, D. J. (2002). A Somatic Cell Genetic System for Dissecting Hemopoietic Cytokine Signal Transduction. J. Biol. Chem. 277: 25624-25630 [Abstract] [Full Text]  
• Blaydes, S. M., Kogan, S. C., Truong, B.-T. H., Gilbert, D. J., Jenkins, N. A., Copeland, N. G., Largaespada, D. A., Brannan, C. I. (2001). Retroviral Integration at the Epi1 Locus Cooperates with Nf1 Gene Loss in the Progression to Acute Myeloid Leukemia. J. Virol. 75: 9427-9434 [Abstract] [Full Text]  
• Arsura, M., Hofmann, C. S., Golay, J., Introna, M., Sonenshein, G. E. (2000). A-myb rescues murine B-cell lymphomas from IgM-receptor-mediated apoptosis through c-myc transcriptional regulation. Blood 96: 1013-1020 [Abstract] [Full Text]  
• Amanullah, A., Hoffman, B., Liebermann, D. A. (2000). Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15INK4B and p16INK4A. Blood 96: 475-482 [Abstract] [Full Text]  
• Schmidt, M., Nazarov, V., Stevens, L., Watson, R., Wolff, L. (2000). Regulation of the Resident Chromosomal Copy of c-myc by c-Myb Is Involved in Myeloid Leukemogenesis. Mol. Cell. Biol. 20: 1970-1981 [Abstract] [Full Text]  
• Sjin, R. M. T. T., Lord, K. A., Abdollahi, A., Hoffman, B., Liebermann, D. A. (1999). Interleukin-6 and Leukemia Inhibitory Factor Induction of JunB Is Regulated by Distinct Cell Type-specific Cis-acting Elements. J. Biol. Chem. 274: 28697-28707 [Abstract] [Full Text]  
• Bies, J., Nazarov, V., Wolff, L. (1999). Identification of Protein Instability Determinants in the Carboxy-Terminal Region of c-Myb Removed as a Result of Retroviral Integration in Murine Monocytic Leukemias. J. Virol. 73: 2038-2044 [Abstract] [Full Text]  
• Krishnaraju, K., Hoffman, B., Liebermann, D. A. (1998). The Zinc Finger Transcription Factor Egr-1 Activates Macrophage Differentiation in M1 Myeloblastic Leukemia Cells. Blood 92: 1957-1966 [Abstract] [Full Text]  
• Woo, C. H., Sopchak, L., Lipsick, J. S. (1998). Overexpression of an Alternatively Spliced Form of c-Myb Results in Increases in Transactivation and Transforms Avian Myelomonoblasts. J. Virol. 72: 6813-6821 [Abstract] [Full Text]  
• Tong, B., Grimes, H. L., Yang, T.-Y., Bear, S. E., Qin, Z., Du, K., El-Deiry, W. S., Tsichlis, P. N. (1998). The Gfi-1B Proto-Oncoprotein Represses p21WAF1 and Inhibits Myeloid Cell Differentiation. Mol. Cell. Biol. 18: 2462-2473 [Abstract] [Full Text]  
• Golay, J., Broccoli, V., Lamorte, G., Bifulco, C., Parravicini, C., Pizzey, A., Thomas, N. S. B., Delia, D., Ferrauti, P., Vitolo, D., Introna, M. (1998). The A-Myb Transcription Factor Is a Marker of Centroblasts In Vivo. J. Immunol. 160: 2786-2793 [Abstract] [Full Text]  
• Reddy, I.-H. O. a. E. P. (1998). The C-Terminal Domain of B-Myb Acts As a Positive Regulator of Transcription and Modulates Its Biological Functions. Mol. Cell. Biol. 18: 499-511 [Abstract] [Full Text]  
• Oh, I.-H., Reddy, E. P. (1997). Murine A-myb Gene Encodes a Transcription Factor, Which Cooperates with Ets-2 and Exhibits Distinctive Biochemical and Biological Activities from c-myb. J. Biol. Chem. 272: 21432-21443 [Abstract] [Full Text]  
• Dash, A B, Orrico, F C, Ness, S A (1996). The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb.. Genes Dev. 10: 1858-1869 [Abstract]  
• Zhuang, H., Niu, Z., He, T.-C., Patel, S. V., Wojchowski, D. M. (1995). Erythropoietin-dependent Inhibition of Apoptosis Is Supported by Carboxyl-truncated Receptor Forms and Blocked by Dominant-negative Forms of Jak2. J. Biol. Chem. 270: 14500-14504 [Abstract] [Full Text]  
• Toth, C. R., Hostutler, R. F., Baldwin, A. S.:Jr., Bender, T. P. (1995). Members of the Nuclear Factor kappaB Family Transactivate the Murine c-myb Gene. J. Biol. Chem. 270: 7661-7671 [Abstract] [Full Text]